Kantar Health thought leaders are available to comment on a variety of healthcare- and pharma-industry-related topics. In addition, our proprietary data is available for media use, including patient population sizes, treatment rates and patient-reported behaviors and attitudes.

Contact the media team:
info@kantarhealth.com

Kantar Health News Room: Delivering the most current and unique insights on healthcare trends RSS Feed News

  • MS Patients' Quality of Life Is Lowest Regarding Personal Relationships

    Aug 8, 2013
    Multiple sclerosis (MS) patients rate their quality of life lowest with respect to their relationships with family and friends and activities of daily living, according to new research from Kantar Health.
    Continue Reading | Share
  • Kantar Health Americas CEO Mike Kelly Named to PharmaVOICE 100 for 2013

    Aug 1, 2013
    Kantar Health is pleased to announce that Kantar Health Americas CEO Mike Kelly has been honored as part of the 2013 PharmaVOICE “100 Most Inspiring People,” an annual recognition in the publication’s July/August edition.
    Continue Reading | Share
  • Kantar Health Presents Recent Clinical Developments in Oncology

    Jun 27, 2013
    Kantar Health announced that it will host its ninth annual seminar highlighting the implications of recent drug approvals and clinical results in the oncology competitive landscape in Tokyo.
    Continue Reading | Share
  • Kantar Health Study Shows 4 in 10 Psoriasis Patients Do Not See a Physician for Their Condition

    Jun 6, 2013
    Four in 10 psoriasis patients—including 25 percent of moderate to severe patients—currently are not under the care of a physician for their condition.
    Continue Reading | Share
  • Kantar Health Launches CancerMPact Biomarker Analysis

    May 23, 2013
    Kantar Health today announced the availability of CancerMPact® Biomarker Analysis, a global offer that examines biomarker segmentation in the current and evolving oncology landscape.
    Continue Reading | Share
  • Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics

    May 21, 2013
    Patients with type 1 diabetes (T1D) who are treated with insulin pump therapy have better glycemic control as measured by significantly lower HbA1C levels than patients with T1D who treat their condition with insulin injections, according to new findings from the National Health and Wellness Survey (NHWS).
    Continue Reading | Share
  • Two in Three Cancer Patients Are Non-Adherent with Their Medications, According to Kantar Health Research

    May 21, 2013
    Two-thirds of patients who have been diagnosed with leukemia, melanoma or non-small cell lung cancer reported that they engage in at least one type of non-adherent behavior in their medicine use, according to new findings from the National Health and Wellness Survey (NHWS).
    Continue Reading | Share
  • Kantar Health Pinpoints Key Abstracts Expected to Generate Strong Buzz at ASCO 2013

    May 15, 2013
    Kantar Health, a leading global healthcare consulting firm, has identified the top abstracts expected to generate the most interest at the annual meeting of the American Society of Clinical Oncology (ASCO). The 2013 meeting promises to be packed with the latest data and trends from the world of oncology.
    Continue Reading | Share
  • Kantar Health to Present at PBIRG Annual General Meeting

    May 14, 2013
    Kantar Health today announced that three of its thought leaders will present at the 2013 PBIRG Annual General Meeting in Naples, Fla., May 19-22.
    Continue Reading | Share
  • Kantar Health Data Show Zytiga Is Most Used First-Line Treatment in Prostate Cancer

    Apr 23, 2013
    Zytiga® (abiraterone acetate, Janssen) is now the most used first-line treatment in Stage IV prostate cancer patients in the United States, according to new findings from CancerMPact® Monthly Drugs and Regimens.
    Continue Reading | Share
Page